Indications for sentinel lymph node biopsy in node-negative oral cancers.
indication
neck dissection
node-negative
oral cavity cancer
sentinel lymph node biopsy
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
24
05
2023
received:
14
09
2022
accepted:
22
07
2023
medline:
25
9
2023
pubmed:
8
8
2023
entrez:
8
8
2023
Statut:
ppublish
Résumé
We aimed to define the indications for sentinel lymph node biopsy (SLNB), the third option for cervical treatment in oral cancer with negative cervical lymph nodes. The greatest depth of invasion (DOI) and long diameter (LD) of the primary site were used as exposures. SLN metastasis was considered the outcome. In three trials conducted between 2009 and 2016, 158 patients were eligible and reassigned to this study group. The scatterplot based on the respective values of DOI and LD would eventually be divided into three sections. In cases of sections T1, T2, and T3, the proportions of SLN metastasis positivity were 21.3%, 35.3%, and 51.2%, respectively. In certain cases of T1 with 2 mm < DOI ≤ 5 mm and 8 mm < LD ≤ 20 mm, the proportion of SLN metastasis positivity was 40.9%. SLNB-navigated or assisted neck dissection can be added as an effective procedure for N0 neck control.
Sections du résumé
BACKGROUND
We aimed to define the indications for sentinel lymph node biopsy (SLNB), the third option for cervical treatment in oral cancer with negative cervical lymph nodes.
METHODS
The greatest depth of invasion (DOI) and long diameter (LD) of the primary site were used as exposures. SLN metastasis was considered the outcome.
RESULTS
In three trials conducted between 2009 and 2016, 158 patients were eligible and reassigned to this study group. The scatterplot based on the respective values of DOI and LD would eventually be divided into three sections. In cases of sections T1, T2, and T3, the proportions of SLN metastasis positivity were 21.3%, 35.3%, and 51.2%, respectively. In certain cases of T1 with 2 mm < DOI ≤ 5 mm and 8 mm < LD ≤ 20 mm, the proportion of SLN metastasis positivity was 40.9%.
CONCLUSIONS
SLNB-navigated or assisted neck dissection can be added as an effective procedure for N0 neck control.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2533-2543Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology, Head and Neck Cancers Version 3.2021. 2021. Accessed September 19, 2021. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1437
D'Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373(6):521-529.
Garrel R, Poissonnet G, Moya Plana A, et al. Equivalence randomized trial to compare treatment on the basis of sentinel node biopsy versus neck node dissection in operable T1-T2N0 oral and oropharyngeal cancer. J Clin Oncol. 2020;38(34):4010-4018.
Hasegawa Y, Tsukahara K, Yoshimoto S, et al. Neck dissections based on sentinel lymph node navigation versus elective neck dissections in early oral cancers: a randomized, multicenter, and noninferiority trial. J Clin Oncol. 2021;39(18):2025-2036.
Kim DH, Kim Y, Kim SW, Hwang SH. Usefulness of sentinel lymph node biopsy for oral cancer: a systematic review and meta-analysis. Laryngoscope. 2021;131(2):E459-E465.
Saleem MI, Peng T, Zhu D, Wong A, Pereira LM, Tham T. Sentinel lymph node biopsy versus elective node dissection in stage cT1-2N0 oral cavity cancer. Laryngoscope. 2022;132(5):989-998.
Miura K, Hirakawa H, Uemura H, et al. Sentinel node biopsy for oral cancer: a prospective multicenter phase II trial. Auris Nasus Larynx. 2017;44(3):319-326.
Yokoyama J, Hasegawa Y, Sugasawa M, et al. Long term-follow-up multicenter feasibility study of ICG fluorescence-navigated sentinel node biopsy in oral cancer. Mol Clin Oncol. 2020;13(4):41.
Amin MB, Gress DM, Vega LRM, Edge SB. AJCC Cancer Staging Manual. Vol 8. Springer; 2017.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452-458.
Melchers LJ, Schuuring E, van Dijk BAC, et al. Tumour infiltration depth ≥4 mm is an indication for an elective neck dissection in pT1cN0 oral squamous cell carcinoma. Oral Oncol. 2012;48(4):337-342.
van Lanschot CGF, Klazen YP, de Ridder MAJ, et al. Depth of invasion in early stage oral cavity squamous cell carcinoma: the optimal cut-off value for elective neck dissection. Oral Oncol. 2020;111:104940.
Crean SJ, Hoffman A, Potts J, Fardy MJ. Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV. Head Neck. 2003;25(9):758-762.
Mizrachi A, Migliacci JC, Montero PH, et al. Neck recurrence in clinically node-negative oral cancer: 27-year experience at a single institution. Oral Oncol. 2018;78:94-101.
Piazza C, Grammatica A, Montalto N, Paderno A, Del Bon F, Nicolai P. Compartmental surgery for oral tongue and floor of the mouth cancer: oncologic outcomes. Head Neck. 2019;41(1):110-115.
Murthy SP, Thankappan K, Jayasankaran SC, et al. “Deep extrinsic muscle involvement” is a fallacy in the American Joint Committee on Cancer's seventh edition of tumor staging of oral cavity cancers. J Oral Maxillofac Surg. 2018;76(1):206-212.
Calabrese L, Giugliano G, Bruschini R, et al. Compartmental surgery in tongue tumours: description of a new surgical technique. Acta Otorhinolaryngol Ital. 2009;29(5):259-264.
Tagliabue M, Gandini S, Maffini F, et al. The role of the T-N tract in advanced stage tongue cancer. Head Neck. 2019;41(8):2756-2767.
Govers TM, Takes RP, Baris Karakullukcu M, et al. Management of the N0 neck in early stage oral squamous cell cancer: a modeling study of the cost-effectiveness. Oral Oncol. 2013;49(8):771-777.
Hernando J, Villarreal P, Alvarez-Marcos F, Garcia-Consuegra L, Gallego L, Junquera L. Sentinel node biopsy versus elective neck dissection. Which is more cost-effective? A prospective observational study. J Craniomaxillofac Surg. 2016;44(5):550-556.
O'Connor R, Pezier T, Schilling C, McGurk M. The relative cost of sentinel lymph node biopsy in early oral cancer. J Craniomaxillofac Surg. 2013;41(8):721-727.
Kosuda S, Kusano S, Kohno N, et al. Feasibility and cost-effectiveness of sentinel lymph node radiolocalization in stage N0 head and neck cancer. Arch Otolaryngol Head Neck Surg. 2003;129(10):1105-1109.
National Institute for Health and Care Excellence. National Institute for Health and Care Excellence: Clinical Guidelines. Vol NICE Guideline, No. 36. National Institute for Health and Care Excellence; 2016.
Hirakawa H, Matsuzuka T, Uemura H, et al. Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 status. Auris Nasus Larynx. 2022;49(4):680-689.
Brouwer de Koning SG, Karakullukcu MB, Lange CAH, Ruers TJM. The oral cavity tumor thickness: measurement accuracy and consequences for tumor staging. Eur J Surg Oncol. 2019;45(11):2131-2136.
Filauro M, Missale F, Marchi F, et al. Intraoral ultrasonography in the assessment of DOI in oral cavity squamous cell carcinoma: a comparison with magnetic resonance and histopathology. Eur Arch Otorhinolaryngol. 2021;278(8):2943-2952.
Iida Y, Kamijo T, Kusafuka K, et al. Depth of invasion in superficial oral tongue carcinoma quantified using intraoral ultrasonography. Laryngoscope. 2018;128(12):2778-2782.
Chen CH, Hsu MY, Jiang RS, Wu SH, Chen FJ, Liu SA. Shrinkage of head and neck cancer specimens after formalin fixation. J Chin Med Assoc. 2012;75(3):109-113.
Waech T, Pazahr S, Guarda V, Rupp NJ, Broglie MA, Morand GB. Measurement variations of MRI and CT in the assessment of tumor depth of invasion in oral cancer: a retrospective study. Eur J Radiol. 2021;135:109480.
Dedhia A, Gosavi S, Sharma B, Pagey R. Low lymphatic vessel density correlates with lymph node metastasis in oral squamous cell carcinoma. J Dent. 2018;19(1):6-14.